BPH - Benign Prostatic Enlargement - Results from #1580

REVIEW UroToday

Does prostate volume affect the efficacy of α1D/A: Adrenoceptor antagonist naftopidil? February 16, 2016

Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia February 15, 2016

Thulium laser enucleation of the prostate is a safe and a highly effective modality for the treatment of benign prostatic hyperplasia - Our experience of 236 patients February 15, 2016

The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance February 11, 2016

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia February 11, 2016

Economic Evaluation Study (Cheer Compliant) Laser Prostatectomy for Benign Prostatic Hyperplasia: Outcomes and Cost-effectiveness February 10, 2016

Differentiating Transition Zone Cancers From Benign Prostatic Hyperplasia by Quantitative Multiparametric Magnetic Resonance Imaging February 10, 2016

Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome February 10, 2016

The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome February 10, 2016

Men With Severe Lower Urinary Tract Symptoms Are at Increased Risk of Depression February 10, 2016

Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia February 9, 2016

A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection February 9, 2016

Biased α-adrenergic receptor and βarrestin signaling in a cell culture model of benign prostatic hyperplasia. February 8, 2016

Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence February 5, 2016

Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study. February 5, 2016

Transitional Zone Index as a Predictor of the Efficacy of α-Blocker and 5α-Reductase Inhibitor Combination Therapy in Korean Patients with Benign Prostatic Hyperplasia. February 4, 2016

Fruit and Vegetable Intake in Relation to Lower Urinary Tract Symptoms and Erectile Dysfunction Among Southern Chinese Elderly Men: A 4-Year Prospective Study of Mr OS Hong Kong February 2, 2016

Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment-the QUALIPROST study February 1, 2016

Intravesical Prostatic Protrusion as a Predicting Factor for the Adverse Clinical Outcome in Patients with Symptomatic Benign Prostatic Enlargement Treated with Dutasteride February 1, 2016

A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up February 1, 2016

Page 80 of 140